Emergent BioSolutions (EBS) Updates on BioThrax Talks with CDC; Follow-on Procurement Contract Still in Negotiations
Tweet Send to a Friend
Emergent BioSolutions Inc. (NYSE : EBS) provided an update on the status of its 2011 BioThrax (Anthrax Vaccine Adsorbed) procurement ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
